Results 21 to 30 of about 181,956,994 (291)

Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update [PDF]

Annals of Surgical Oncology, 2016
Purpose A joint American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology panel convened to develop a focused update of the American Society of Clinical Oncology guideline concerning use of postmastectomy radiotherapy (PMRT).
Recht, Abram, Comen, Elizabeth A., Fine, Richard E., Fleming, Gini F., Hardenbergh, Patricia H., Ho, Alice Y., Hudis, Clifford A., Hwang, E. Shelley, Kirshner, Jeffrey J., Morrow, Monica, Salerno, Kilian E., Sledge, George W., Solin, Lawrence J., Spears, Patricia A., Whelan, Timothy J., Somerfield, Mark R., Edge, Stephen B.   +16 more
openaire   +4 more sources

The role of the gastrectomy on survival in metastatic gastric cancer patients: A multicenter study of Anatolian Society of Medical Oncology (ASMO)

, 2015
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer -- MAY 29-JUN 02, 2015 -- Chicago, IL…Amer Soc Clin ...
Menekse, Serkan, Zengin, Nurullah, Eren, Tulay, Aksoy, Sercan, Goksel, Gamze, Ozdemir, Nuriye, Sendur, Mehmet Ali Nahit, Hacibekiroglu, Ilhan, Ozkan, Metin, Duran, Ayse Ocak, Arpaci, Erkan, Bilgetekin, Irem, Kacan, Turgut, Yazici, Ozan, Aksoy, Asude, Karaca, Halit   +15 more
core   +2 more sources

Recommendations from the ASCO Academic Global Oncology Task Force

JCO Global Oncology, 2020
In recognition of the rising incidence and mortality of cancer in low- and middle-resource settings, as well as the increasingly international profile of its membership, ASCO has prioritized efforts to enhance its engagement at a global level.
Julie R. Gralow, Fredrick Chite Asirwa, Ami Siddharth Bhatt, Maria T. Bourlon, Quyen Chu, Alexandru E. Eniu, Patrick J. Loehrer, Gilberto Lopes, Lawrence N. Shulman, Julia Close, Jamie Von Roenn, Michal Tibbits, Doug Pyle   +12 more
doaj   +1 more source

New Targeted Therapies and Combinations of Treatments for Cervical, Endometrial, and Ovarian Cancers: A Year in Review

Current Oncology, 2022
This review of the meaningful data from 2021 on cervical, endometrial, and ovarian cancers aims to provide an update of the most clinically relevant studies presented at important oncologic congresses during the year (the American Society of Clinical ...
Adelina Silvana Gheorghe, Elena Adriana Dumitrescu, Isabela Anda Komporaly, Raluca Ioana Mihăilă, Cristian Virgil Lungulescu, Dana Lucia Stănculeanu   +5 more
doaj   +1 more source

Cross-Cultural Validity Study of a Medical Education Leadership Competencies Instrument in Latin American Physicians: A Multinational Study

Journal of Global Oncology, 2019
PURPOSE: Physicians rarely receive formal training in leadership skills. Çitaku and colleagues have identified a set of leadership competencies (LCs) providing validity evidence in North American (NA) and European Union (EU) medical education ...
Max S. Mano, Rafaela Gomes, Gustavo Werutsky, Carlos H. Barrios, Gustavo Nader Marta, Cynthia Villarreal-Garza, Antonio Luiz Frasson, Cinthya Sternberg, Renan Clara, Sergio D. Simon, Fadil Çitaku, Marianne Waldrop, Claudio Violato, Don Zillioux, Yawar Hayat Khan   +14 more
doaj   +1 more source

Chemotherapy-induced nausea and vomiting prophylaxis in pediatric patients at a teaching hospital: assessment of adherence to guidelines

Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde, 2023
Aims: Describing the adherence rate of antiemetic prophylaxis in pediatric patients using antineoplastic agents and possible associated factors. Methods: It is a retrospective cross-sectional study, which took place in a teaching hospital at Belo ...
Safira R. ALVES, Iwyson H. COSTA, Camila S. LIMA, Ronara C. GROIA-VELOSO, Georgiane C. OLIVEIRA, Clarice CHEMELLO   +5 more
doaj   +1 more source

2021 Update on Systemic Therapy for Breast Cancer

healthbook TIMES. Oncology Hematology, 2022
Over the past years, new systemic therapies for advanced and metastatic breast cancer have emerged, resulting in significantly improved survival outcomes in this patient population.
Anton Oseledchyk, Christian Kurzeder, Angela Kohler, Marcus Vetter   +3 more
doaj   +1 more source

SPECIAL ISSUE : "Integrative medicine in oncology: another step forward" - EDITORIAL - Setting an Integrative Medicine Oncology Network in Italy: a holistic approach to people with cancer

Journal of Cancer Rehabilitation, 2021
Health professionals involved in oncology care should make more efforts in developing a holistic attitude by placing the person and their needs at the center of their attention. Such an integrative approach has been the subject of in-depth studies and is
Vittorio Gebbia, Carmela Amato, Andrea Bonacchi, Rosalba Contentezza, Rossella Guggino, Vito Marino, Stefano Magno, Matteo Pennisi, Dario Piazza, Paolo Tralongo   +9 more
doaj   +1 more source

The clinical and pathologic characteristics of 400 gastrointestinal stroinal tumor patients from Turkey: The final results of the Turkish Anatolian Society of Medical Oncology Multicenter Registery

, 2014
50th Annual Meeting of the American-Society-of-Clinical-Oncology -- MAY 30-JUN 03, 2014 -- Chicago, ILWOS: 000358613200571[Abstract Not Available]American Society of Clinical ...
Cihan, Şener, Özkan, Metin, Uncu, Doğan, Sevinç, Alper, Kaplan, Mehmet Ali, Öksüzoğlu, Berna, Üyetürk, Ümmügül, Dane, Faysal, Benekli, Mustafa, Yıldız, Ramazan, Bilici, Ahmet, Şeker, Mesut, Özdemir, Nuriye, Gümüş, Mahmut, Salepçi, Tafian, Işıkdoğan, Abdurrahman, Karaca, Halit, Yildiz, Ramazan, Isikdogan, Abdurrahman, Bilicl, Ahmet   +19 more
core   +1 more source

American Society of Clinical Oncology 2010 colorectal update [PDF]

Expert Review of Anticancer Therapy, 2010
The 2010 American Society of Clinical Oncology (ASCO) Gastrointestinal (Colorectal) Cancer Track included several notable presentations. The addition of cetuximab to FOLFOX in stage III colon cancer did not improve disease-free survival, but increased toxicity. In the metastatic setting, cetuximab demonstrated benefit only in a small subset of patients
Janet E, Murphy, David P, Ryan
openaire   +2 more sources